Improving early infant diagnosis for HIV-exposed infants using unmanned aerial vehicles for blood sample transportation in Conakry, Guinea: a comparative cost-effectiveness analysis.
HIV
Health economics
Paediatrics
Public Health
Screening
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
06
04
2023
accepted:
30
08
2023
medline:
22
11
2023
pubmed:
21
11
2023
entrez:
20
11
2023
Statut:
ppublish
Résumé
Early infant diagnosis (EID) for HIV-exposed infants is essential due to high mortality during the first months of their lives. In Conakry (Guinea), timely EID is difficult as traffic congestion prevents the rapid transport of blood samples to the central laboratory. We investigated the cost-effectiveness of transporting EID blood samples by unmanned aerial vehicles (UAV), also known as drones. Using Monte Carlo simulations, we conducted a cost-effectiveness comparative analysis between EID blood samples transportation by on-demand UAV transportation versus the baseline scenario (ie, van with irregular collection schedules) and compared with a hypothetic on-demand motorcycle transportation system. Incremental cost-effectiveness ratio (ICER) per life-year gained was computed. Simulation models included parameters such as consultation timing (eg, time of arrival), motorcycle and UAV characteristics, weather and traffic conditions. Over the 5-year period programme, the UAV and motorcycle strategies were able to save a cumulative additional 834.8 life-years (585.1-1084.5) and 794.7 life-years (550.3-1039.0), respectively, compared with the baseline scenario. The ICER per life-year gained found were US$535 for the UAV strategy versus baseline scenario, US$504 for the motorcycle strategy versus baseline scenario and US$1137 per additional life-year gained for the UAV versus motorcycle strategy. Respectively, those ICERs represented 44.8%, 42.2% and 95.2% of the national gross domestic product (GDP) per capita in Guinea-that is, US$1194. Compared with the baseline strategy, both transportation of EID blood samples by UAVs or motorcycles had a cost per additional life-year gained below half of the national GDP per capita and could be seen as cost-effective in Conakry. A UAV strategy can save more lives than a motorcycle one although the cost needed per additional life-year gained might need to consider alongside budget impact and feasibility considerations.
Sections du résumé
BACKGROUND
BACKGROUND
Early infant diagnosis (EID) for HIV-exposed infants is essential due to high mortality during the first months of their lives. In Conakry (Guinea), timely EID is difficult as traffic congestion prevents the rapid transport of blood samples to the central laboratory. We investigated the cost-effectiveness of transporting EID blood samples by unmanned aerial vehicles (UAV), also known as drones.
METHODS AND FINDINGS
RESULTS
Using Monte Carlo simulations, we conducted a cost-effectiveness comparative analysis between EID blood samples transportation by on-demand UAV transportation versus the baseline scenario (ie, van with irregular collection schedules) and compared with a hypothetic on-demand motorcycle transportation system. Incremental cost-effectiveness ratio (ICER) per life-year gained was computed. Simulation models included parameters such as consultation timing (eg, time of arrival), motorcycle and UAV characteristics, weather and traffic conditions. Over the 5-year period programme, the UAV and motorcycle strategies were able to save a cumulative additional 834.8 life-years (585.1-1084.5) and 794.7 life-years (550.3-1039.0), respectively, compared with the baseline scenario. The ICER per life-year gained found were US$535 for the UAV strategy versus baseline scenario, US$504 for the motorcycle strategy versus baseline scenario and US$1137 per additional life-year gained for the UAV versus motorcycle strategy. Respectively, those ICERs represented 44.8%, 42.2% and 95.2% of the national gross domestic product (GDP) per capita in Guinea-that is, US$1194.
CONCLUSION
CONCLUSIONS
Compared with the baseline strategy, both transportation of EID blood samples by UAVs or motorcycles had a cost per additional life-year gained below half of the national GDP per capita and could be seen as cost-effective in Conakry. A UAV strategy can save more lives than a motorcycle one although the cost needed per additional life-year gained might need to consider alongside budget impact and feasibility considerations.
Identifiants
pubmed: 37984898
pii: bmjgh-2023-012522
doi: 10.1136/bmjgh-2023-012522
pmc: PMC10660963
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
Public Health Action. 2017 Jun 21;7(2):83-89
pubmed: 28695079
PLoS Med. 2015 Nov 03;12(11):e1001897
pubmed: 26528913
Lancet HIV. 2021 Jun;8(6):e353-e362
pubmed: 33932330
Infect Dis Poverty. 2022 Jul 15;11(1):82
pubmed: 35841117
BMC Health Serv Res. 2014 May 02;14:201
pubmed: 24885453
Vaccine. 2016 Jul 25;34(34):4062-7
pubmed: 27340098
BMC Public Health. 2011 Jul 13;11:553
pubmed: 21749730
Lancet HIV. 2019 Jun;6(6):e373-e381
pubmed: 30987937
AIDS. 2012 Nov 28;26(18):2361-73
pubmed: 22948267
Lancet Glob Health. 2020 Jan;8(1):e143-e151
pubmed: 31839129
Int J Health Policy Manag. 2017 Jan 22;6(10):601-603
pubmed: 28949475
Clin Infect Dis. 2018 Aug 16;67(5):701-707
pubmed: 29490026
BMC Infect Dis. 2022 Feb 8;22(1):134
pubmed: 35135474
Lancet. 2004 Oct 2-8;364(9441):1236-43
pubmed: 15464184
Int J Health Policy Manag. 2021 Nov 01;10(11):673-677
pubmed: 33619929
Trans R Soc Trop Med Hyg. 2020 Apr 8;114(4):308-314
pubmed: 31943110
PLoS One. 2020 Jul 7;15(7):e0235572
pubmed: 32634140
BMC Pregnancy Childbirth. 2020 Sep 4;20(1):509
pubmed: 32887567
Best Pract Res Clin Obstet Gynaecol. 2019 Nov;61:66-74
pubmed: 31128974
Value Health. 2016 Dec;19(8):929-935
pubmed: 27987642
JAMA. 1996 Oct 16;276(15):1253-8
pubmed: 8849754
BMC Health Serv Res. 2021 Dec 5;21(1):1308
pubmed: 34863156
PLoS One. 2012;7(5):e36966
pubmed: 22693561
PLoS One. 2015 Jul 29;10(7):e0134020
pubmed: 26222261
Lancet Glob Health. 2022 Apr;10(4):e564-e569
pubmed: 35303465
J Int AIDS Soc. 2013 Jan 02;16:18026
pubmed: 23305696
AIDS. 2021 Feb 2;35(2):287-297
pubmed: 33394672
Sensors (Basel). 2017 Jan 14;17(1):
pubmed: 28098819
Lancet. 2006 Apr 1;367(9516):1066-1074
pubmed: 16581405
BMJ Glob Health. 2019 Jul 30;4(4):e001541
pubmed: 31413873
AIDS. 2013 Nov 13;27(17):2787-97
pubmed: 24056068